Shu Li

机构：Shandong University, Northeast Agricultural University, Shanghai Jiao Tong University, Anhui University of Traditional Chinese Medicine, Second Affiliated Hospital of Nanjing Medical University, Second Affiliated Hospital of Zhejiang University, Weihai Science and Technology Bureau · ORCID：0000-0003-4609-4666

发表论文 102 篇 · 总被引 1703 次 · h-index 24

代表论文

• Antiviral PROTACs: Opportunity borne with challenge (2023 · Cell Insight · 被引 67)
• Gut microbiota in the early stage of Crohn’s disease has unique characteristics (2022 · Gut Pathogens · 被引 54)
• Role of m6A modification and novel circ_0066715/ miR-486-5p/ ETS1 axis in rheumatoid arthritis macrophage polarization progression (2022 · Aging · 被引 35)
• The pathogenesis of amyotrophic lateral sclerosis: Mitochondrial dysfunction, protein misfolding and epigenetics (2022 · Brain Research · 被引 24)
• Chronic obstructive pulmonary disease as a risk factor for cognitive impairment: a systematic review and meta-analysis (2024 · BMJ Open Respiratory Research · 被引 20)
• Dietary selenomethionine reduced oxidative stress by resisting METTL3-mediated m6A methylation level of Nrf2 to ameliorate LPS-induced liver necroptosis in laying hens (2024 · The Journal of Nutritional Biochemistry · 被引 20)